Published in Cancer Weekly, May 5th, 2009
"In this study, we immunohistochemically assessed for clusterin in 97 skin biopsy specimens, including 70 MF eases and 27 other cutaneous neoplasms including ALCL, peripheral T-cell lymphoma unspecified (PTCL), and lymphomatoid papulosis (LyP). Clustel-in was positive in 36 (51%) of 70 cases of MF and correlated with clinical stage in 68 cases: 3 of 21 stage I, II of 20 stage II, and 23 of 27 stage III/IV. Clusterin expression also correlated with type of skin...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.